- Blood plasma collection, which involves extracting vital components like immunoglobulins and clotting factors, has become a cornerstone of modern therapeutic solutions in the U.S. healthcare system, particularly for treating rare, chronic, and immune-related disorders. Its increasing relevance stems from the surging demand for plasma-derived therapies across both public and private healthcare sectors
- The growing need for immunoglobulin therapies, advancements in plasmapheresis technology, and government initiatives supporting biologics manufacturing are major factors fueling the demand for efficient plasma collection infrastructure across the U.S.
- The automated plasma collection segment dominated the largest market revenue share of 68.9% in 2024, driven by its improved efficiency, higher plasma yield, and enhanced donor comfort compared to manual methods
